Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2018-10-01
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage
NCT01533584
Compliance of Blood Pressure and Lipid in Hypertensive Patients Under the Management of Hospitals at Different Levels
NCT04015843
COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication
NCT01274494
ESH ABPM COVID-19 STUDY
NCT05167240
The Effect of Pharmacist Intervention on Blood Pressure Control
NCT01233193
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres. Blood pressure will be measured as usually done in the office, but care will be adopted to make measurements highly standardized in all Centres.
The primary goals will be to determine the global, regional and country rates of hypertension control in Europe. Other goals will be to identify global and regional factors associated with blood pressure control in different European regions. It is well known that the overall control of hypertension in Europe is still insufficient. However, the problem is not the same across Europe. Differences in healthcare systems exist among European countries, and in some countries government healthcare system only partially reimburse costs of antihypertensive therapy. There are also differences in gross national product, educational levels, salt consumption, prevalence of obesity and other aspects. These could cause dissimilarities in hypertension prevalence, achieved blood pressure control and cardiovascular mortality among European regions.
The results obtained in the BP-CON-ESH project will be used to refine treatment strategies for improvement of blood pressure control and will serve as a basis for assessing future changes and trends in Europe.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Terminal malignancy, reduced life expectancy (\<6 months)
* Amputated limb
* Dementia
* Patients living in a nursing home
* Unsigned informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Society of Hypertension
OTHER
Clinical Hospital Centre Zagreb
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Bojan Jelaković
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bojan Jelaković, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Clinical Hospital Centre Zagreb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of Preventive Cardiology, Yerevan
Yerevan, , Armenia
Klinikum Wels-Grieskirchen
Wels, , Austria
Erasmus Hospital
Brussels, , Belgium
CHU de Liège
Liège, , Belgium
Ambroise Paré University Hospital
Mons, , Belgium
University Hospital "St. Anna"
Sofia, , Bulgaria
University hospital centre Zagreb
Zagreb, City of Zagreb, Croatia
Charles University Medical School and University Hospital
Pilsen, , Czechia
Center for Hypertension, Charles University, Prague
Prague, , Czechia
Institute for Clinical and Experimental Medicine (IKEM) and Thomayer Hospital, Prague
Prague, , Czechia
Tallinn Hypertension Excellence Centre
Tallinn, , Estonia
Hypertension Center Berlin Charité
Berlin, , Germany
Hypertoniezentrum Bonn
Bonn, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Universitätskliniken des Saarlandes
Homburg, , Germany
Hypertension Center Munich
Munich, , Germany
Hypertension and Cardiovascular Prevention Clinic, 3rd Department of Medicine, Evangelismos Hospital
Athens, , Greece
Hypertension Clinic, University Hospital Laiko
Athens, , Greece
University of Athens, Hippokration Hospital
Athens, , Greece
Hypertension Clinic, Department of Cardiology, KAT General Hospital
Athens, , Greece
Hypertension Clinic, Cardiology Department, Asklepeion Hospital
Athens, , Greece
University Hospital of Heraklion
Heraklion, , Greece
Hypertension Center, Department of Nephrology, University Hospital of Ioannina
Ioannina, , Greece
Hypertension Outpatient Clinic, 1st Propedeutic Dept. of Internal Medicine, AHEPA Hospital
Thessaloniki, , Greece
Hypertension Center, Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki
Thessaloniki, , Greece
Aristotle University of Thessaloniki, Papageorgiou General Hospital
Thessaloniki, , Greece
Assuta Ashdod University Hospital
Ashdod, , Israel
Centre of Prevention and Treatment of Arterial Hypertension and Cardiovascular Risk Factors
Brescia, , Italy
S. Luca Hospital, Istituto Auxologico Italiano
Milan, , Italy
Ospedale Niguarda, Dip. De Gasperis e Università di Milano Bicocca
Milan, , Italy
Napoli Hypertension Excellence Centre, Federico II Clinic Research Center for Hypertension and Related Conditions
Napoli, , Italy
Excellence Centre of Hypertension, Department of Medical Sciences, University of Torino
Torino, , Italy
American University Center, Hypertension/Vascular Medicine Division (Associated Centre)
Beirut, , Lebanon
Kaunas Hypertension Excellence Centre
Kaunas, , Lithuania
University Hospital Maastricht
Maastricht, , Netherlands
Radboud University of Nijmegen Medical Center
Nijmegen, , Netherlands
Department of Internal Medicine, Hypertension and Vascular Diseases, Warsaw Medical University
Warsaw, , Poland
Centro Hospitalar do Alto Ave, Minho University
Guimarães, , Portugal
Department of Cardiology and Internal Medicine, Emergency Clinical Hospital of Bucharest
Bucharest, , Romania
Centre for Hypertension of the Clinical Centre of Serbia
Belgrade, , Serbia
Hipertensión Clinic, Internal Medicine, Hospital Clinico, University of Barcelona
Barcelona, , Spain
Hypertension Clinic, Nephrology Department, Reina Sofia University Hospital
Córdoba, , Spain
Danderyd University Hospital
Stockholm, , Sweden
National Scientific Center "The M.D. Strazhesko Institute of Cardiology"
Kyiv, , Ukraine
St. Bartholomew's Royal London School of Medicine & Dentistry
London, , United Kingdom
The Pearl-Rose Clinic (Hypertension & Cardiovascular Risk), Hammersmith Hospital,
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
ESH website with relevant informations on BP CON study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BP-CON-ESH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.